“As the global cell and gene therapy market size continues to increase at an anticipated compound annual growth rate of 50%, our elegant gene-delivery vector platform holds tremendous promise ...

“Gene therapy for aging-related diseases needs efficient delivery vectors. The greater payload of the CMV vector allows delivery of larger or multiple genes, which will be important in the ...